P2Y12 INHIBITOR
Clinical trials for P2Y12 INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new P2Y12 INHIBITOR trials appear
Sign up with your email to follow new studies for P2Y12 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One drug at a time: could a simpler blood thinner strategy cut bleeding risk after stents?
Disease control Recruiting nowThis study tests a new approach for people with atrial fibrillation who have just received a coronary stent. Instead of taking multiple blood thinners together for months, the experimental group takes only one antiplatelet drug for the first month, then switches to a single antic…
Matched conditions: P2Y12 INHIBITOR
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether taking just one blood thinner (single antiplatelet therapy) is safer and as effective as taking two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a balloon procedure to open blocked heart arteries. About 576…
Matched conditions: P2Y12 INHIBITOR
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC